FDA updates labeling for XTAMPZA ER FDA Approval Dec. 31, 2025, 13:45 UTC Labeling changes approved for COLLEGIUM PHARM INC. Active ingredient: OXYCODONE. Decision date: 12/22/2025 Full text
There are no comments here yet...